NCT06686277 Effects Of Gong's Versus Mulligan Mobilization In Patients With Adhesive Capsulitis
| NCT ID | NCT06686277 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Adhesive Capsulitis of Shoulder |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-04-24 |
| Primary Completion | 2025-01-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-04-24 with a primary completion date of 2025-01-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A Randomized Clinical Trial will be conducted at DHQ hospital kasur,BIT hospital kasur,Arif memorial hospital Lahore.Pre-diagnosed patients will be reassessed by applying (Shoulder Shrug Sign, Hand to neck, Hand to scapula, Hand to opposite scapula,Hand to back,Capsular pattern movement restriction)Plus all other special tests will be applied to confirm that symptoms are not due to other shoulder pathologies but are due to just adhesive capsulitis then through consecutive sampling technique on 60 patients they will be allocated using computer generated sampling(random number table) into Group A and Group B.
Eligibility Criteria
Inclusion Criteria: * Age 40 to 50 years * Both male and female * Pre-diagnosed Unilateral Primary Frozen shoulder patients * Prediagnosed Stage 3(Frozen phase) patients(27) Exclusion Criteria: * Patients with previous surgery in the shoulder joint * History of recent fracture or severe trauma to the shoulder * Diagnosed instability or previous history of dislocation * Systemic inflammatory conditions(e.g.rheumatoid arthritis)
Contact & Investigator
Muhammad Hassan, MSPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06686277 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 50 Years, studying Adhesive Capsulitis of Shoulder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06686277 currently recruiting?
Yes, NCT06686277 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06686277 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06686277 clinical trial?
NCT06686277 is sponsored by Riphah International University. The principal investigator is Muhammad Hassan, MSPT at Riphah International University. The trial plans to enroll 60 participants.